Over 5,300 Kenyans suffer from blood disorder

Over 5,300 Kenyans suffer from blood disorder

An estimated 5,300 Kenyans suffer from haemophilia, a rare genetic blood disorder that causes blood not to clot properly. According to statistics from the Kenya Haemophilia Association, one in every 10,000 Kenyans suffers from haemophilia. As World Haemophilia Day is marked, patients in Kenya continue to face a number of challenges such as inaccurate diagnosis, […]

Hemophilia is a genetic disorder in which the blood does not clot properly due to a lack of certain clotting factors.

On the occasion of the “World Hemophilia Day” being commemorated every April 17, the Ministry of Public Health, through the Epidemiology Directorate, highlighted this disease as the main topic in its weekly epidemiological bulletin. Hemophilia is a hereditary bleeding disorder, characterized by the deficiency or absence of factor VIII (hemophilia A) or factor IX (hemophilia B), essential for normal blood clotting. It is a chronic condition linke…

Do you have blood coming out of your nose often? Pay attention that here we will tell you what is and what are the causes of hemophilia. Getting blood out of your nose without an apparent cause can be common and, many times, is not serious; however, you may suffer from hemophilia. So, then we will tell you what this disease is all about.

Hemophilia, an inherited hemorrhagic disease of genetic origin, is linked to alterations in the X chromosome. Mutations in the genes that code for hemostatic factors VIII and IX Friday, April 18, 2025 Friday, April 18, 2025 Municipalities Puebla Hemophilia, a hereditary hemorrhagic disease Salud Mexico.- It looks like a real blood disease, but it can affect everyone equally. It has been suffered by kings and princes, but it is also suffered by t…

NICE issues final guidance for Altuvoct as severe hemophilia A...

The National Institute for Health and Care Excellence (NICE) has issued a final guidance recommending the use of Altuvoct (efanesoctocog alfa) in England and Wales as an option for people with severe hemophilia A, ages 2 and older. The National Health Service, the U.K.’s public healthcare system, is now expected to fund the treatment. “This positive recommendation from NICE is a significant moment for people living with severe hemophilia A in th…